Business

Bionik Laboratories to Present ARKE™ at the 2016 Colloquium on Sports and People with Disabilities at l'Université de Poitiers

Bionik Laboratories to Present ARKE™ at the 2016 Colloquium on Sports and People with Disabilities at l'Université de Poitiers.

articleBionik Laboratories Corp.January 27, 20163/company/bionik-laboratories-corp/news/bionik-laboratories-to-present-arketm-at-the-2016-colloquium-on-sports-and-people-with-disabilities-at-luniversite-de-poitiers
Bionik Laboratories to Present ARKE™ at the 2016 Colloquium on Sports and People with Disabilities at l'Université de Poitiers

About this update from Bionik Laboratories Corp.

[{"type":"text","content":"\n\n\n\nBionik Laboratories to Present ARKE™ at the 2016 Colloquium on Sports and People with Disabilities at l'Université de Poitiers\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nBionik Laboratories to Present ARKE™ at the 2016 Colloquium on Sports and People with Disabilities at l'Université de Poitiers\nCanada NewsWire\nTORONTO, Jan. 27, 2016\n\n\n\n- First live demonstration of ARKE GEN2 proprietary robotic lower-body exoskeleton -\n\n\n\nTORONTO, Jan. 27, 2016 /CNW/ -- Bionik Laboratories Corp. (OTCQX: BNKL), a pioneering medical device and robotics company with a focus in developing technologies and solutions for individuals with neurological disorders (\"Bionik\" or the \"Company\"), announced today that the Company will present at the 2016 Colloquium on Sports and People with Disabilities at l'Université de Poitiers being held February 5, 2016, in Poitiers, France.\n\n\nMichal Prywata, Chief Operating Officer, will discuss the development of Bionik's primary product, ARKE™, a robotic lower-body exoskeleton device designed to allow paraplegics as well as other wheelchair users the ability to rehabilitate through walking and other motion. Bionik expects to report key verification and clinical data on its second generation exoskeleton, ARKE GEN2, from Canadian rehabilitation center testing in mid-2016.\n\n\"Bionik is honored to be invited to participate in this important event highlighting the latest scientific developments related to adaptive living, technology, equipment, materials, prosthetics and connected devices intended to enhance physical and motor abilities of people with disabilities,\" stated Mr. Prywata.\n\nThe Bionik team will present an onsite demonstration of ARKE GEN2, the first comprehensive lower body exoskeleton with tablet control. Following its clinical development and the appropriate health agency approvals, ARKE will initially be used in a rehabilitation environment, with the eventual goal of being made available for home use.\n\n\"Robotic exoskeletons like ARKE have the potential to transform the futur...

More updates from Bionik Laboratories Corp.